PharmiWeb.com - Global Pharma News & Resources

Healthcare - Press Releases

Date Title Company
09-Apr-2024 Companion Diagnostics: Tailoring Treatment for Individual Patients Markets and Markets
08-Apr-2024 Mersey and West Lancashire Teaching Hospitals NHS Trust Teams Up with Netcall to Transform Patient Engagement with Cutting-Edge Digital Solutions Mersey and West Lancashire Teaching Hospitals NHS Trust
08-Apr-2024 OncoZenge Announces Dr. Paolo Bossi as New Member of the Advisory Board OncoZenge
08-Apr-2024 Medicxi Announces $40m investment in D3 Bio Medicxi
08-Apr-2024 Idorsia’s QUVIVIQ™▼ (daridorexant) accepted for restricted use within NHS Scotland to treat insomnia Idorsia UK Ltd
08-Apr-2024 InnoScot Health spinout looks to further catalyse growth with London conference slot InnoScot Health
08-Apr-2024 Scottish Medicines Consortium (SMC) accepts Camzyos®▼(mavacamten) for use on the NHS as an adjunct treatment option for adults with symptomatic obstructive hypertrophic cardiomyopathy Bristol Myers Squibb
08-Apr-2024 World Health Day ‘champions right of all to quality care – and innovation can further bridge the gap’ InnoScot Health
05-Apr-2024 Unlocking Healing for Humans Through Horses: Asterales Equine Therapy Creates a Haven in County Roscommon Asterales Equine Therapy
05-Apr-2024 Chiesi’s carbon minimal inhalers reach innovation milestone as phase III trials now underway Chiesi Group
05-Apr-2024 2024 Global Health Summit Documentary Series — Altasciences Is Transforming the Drug Development Journey for Sponsors Worldwide Altasciences
03-Apr-2024 Nxera Pharma Appoints Experienced Senior Strategy Consultant Patrick Branch as Head of Business Development for Japan and APAC Nxera Pharma
03-Apr-2024 Lindus Health Unveils Versatile “All-in-One Respiratory CRO” Offering Tailored to Respiratory Clinical Trials Lindus Health
03-Apr-2024 Largest ever UK health research programme to benefit from Novartis’ multi-million pound investment Novartis
03-Apr-2024 Veeva Vault CRM Now Available for All New Customers Veeva Systems
03-Apr-2024 Solventum Begins Trading on the New York Stock Exchange Solventum
03-Apr-2024 BellaSeno Appoints Dr. Thomas Lingner as Chief Technology Officer and Inga Freyert as VP Quality and Regulatory Affairs BellaSeno GmbH
02-Apr-2024 Avance Clinical at World Vaccine Congress to Share Latest Vaccine Clinical Trial News Including an HIV-1 Study Avance Clinical
01-Apr-2024 Creative Diagnostics Launches Comprehensive ELISA Based Assays for Vaccine Development Creative Diagnostics
28-Mar-2024 Aragen operationalizes first phase of its Biologics manufacturing facility in India Aragen